In previous studies, we have shown that the RASSF10 promoter is methylated in patient tumors samples of the adrenal gland [24], head and neck [20], sarcoma [20], pancreas carcinoma [20], and Merkel cell carcinoma [25]. This evidence concerns the gene RASSF10 and sarcoma.